Simon Conway is a Senior Managing Director at FTI Consulting and is based in London. Simon is in the Strategic Communications segment and part of the life sciences team.
Simon joined FTI in 2012 from Evolution Securities where he was the research analyst responsible for the biotech and small cap healthcare sector.
Prior to that Simon spent several years on the buy-side including stints at Millennium Capital and Lehman Brothers as the analyst on global healthcare investment portfolios. Before that he was again on the sell-side as the European Biotech analyst at Bear Stearns. He began his City career at Williams de Broë also as a healthcare analyst.
Simon also has first-hand experience of the biotech industry having worked as a scientist at Peptide Therapeutics (Acambis). By profession Simon is a chemist, obtaining his credentials at Imperial College, Cambridge University and Stanford University. His current clients include Angle, Mereo Biopharma, GW Pharma, Consort Medical and Circassia.